Shin‐Hun Juang

2.5k total citations
69 papers, 2.0k citations indexed

About

Shin‐Hun Juang is a scholar working on Molecular Biology, Plant Science and Organic Chemistry. According to data from OpenAlex, Shin‐Hun Juang has authored 69 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 15 papers in Plant Science and 14 papers in Organic Chemistry. Recurrent topics in Shin‐Hun Juang's work include Synthesis and biological activity (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Natural product bioactivities and synthesis (6 papers). Shin‐Hun Juang is often cited by papers focused on Synthesis and biological activity (8 papers), Nitric Oxide and Endothelin Effects (7 papers) and Natural product bioactivities and synthesis (6 papers). Shin‐Hun Juang collaborates with scholars based in Taiwan, United States and Japan. Shin‐Hun Juang's co-authors include Keping Xie, Isaiah J. Fidler, Zhitao Dong, Carl Nathan, Mordechai Gutman, Q W Xie, I. J. Fidler, Pei-Dawn Lee Chao, Yu‐Chi Hou and Chi‐Sheng Shia and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and JNCI Journal of the National Cancer Institute.

In The Last Decade

Shin‐Hun Juang

67 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shin‐Hun Juang Taiwan 25 814 360 327 319 315 69 2.0k
Lucia Anna Stivala Italy 32 2.0k 2.4× 256 0.7× 796 2.4× 341 1.1× 161 0.5× 68 3.3k
Verónique Noé Spain 30 1.8k 2.2× 157 0.4× 444 1.4× 397 1.2× 206 0.7× 109 2.8k
Nam Doo Kim South Korea 32 1.8k 2.2× 454 1.3× 384 1.2× 277 0.9× 274 0.9× 102 2.9k
Raghu Sinha United States 31 1.0k 1.3× 204 0.6× 173 0.5× 234 0.7× 82 0.3× 77 2.4k
Shichang Miao United States 22 647 0.8× 361 1.0× 247 0.8× 127 0.4× 346 1.1× 46 1.6k
Margaret M. Briehl United States 30 1.9k 2.3× 237 0.7× 329 1.0× 487 1.5× 259 0.8× 62 2.8k
Qian Lei China 29 1.1k 1.3× 320 0.9× 249 0.8× 176 0.6× 167 0.5× 85 2.0k
Marina Ignatushchenko United States 9 1.9k 2.4× 304 0.8× 440 1.3× 206 0.6× 236 0.7× 10 2.9k
My‐Hanh Lam United States 21 857 1.1× 238 0.7× 388 1.2× 140 0.4× 148 0.5× 33 2.0k
Andrew F.G. Slater Sweden 14 1.0k 1.3× 158 0.4× 280 0.9× 180 0.6× 261 0.8× 15 2.1k

Countries citing papers authored by Shin‐Hun Juang

Since Specialization
Citations

This map shows the geographic impact of Shin‐Hun Juang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shin‐Hun Juang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shin‐Hun Juang more than expected).

Fields of papers citing papers by Shin‐Hun Juang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shin‐Hun Juang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shin‐Hun Juang. The network helps show where Shin‐Hun Juang may publish in the future.

Co-authorship network of co-authors of Shin‐Hun Juang

This figure shows the co-authorship network connecting the top 25 collaborators of Shin‐Hun Juang. A scholar is included among the top collaborators of Shin‐Hun Juang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shin‐Hun Juang. Shin‐Hun Juang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chuang, Yung‐Jen, et al.. (2023). How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy. Journal of Food and Drug Analysis. 31(3). 387–407. 4 indexed citations
2.
Juang, Shin‐Hun, Min‐Tsang Hsieh, Pei‐Ling Hsu, et al.. (2020). Studies of Coumarin Derivatives for Constitutive Androstane Receptor (CAR) Activation. Molecules. 26(1). 164–164. 5 indexed citations
3.
Huang, Chao‐Yuan, Shu‐Pin Huang, Victor C. Lin, et al.. (2015). Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer. Scientific Reports. 5(1). 8556–8556. 21 indexed citations
4.
Huang, Shu‐Pin, Victor C. Lin, Yung‐Chin Lee, et al.. (2013). Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients. European Journal of Cancer. 49(17). 3729–3737. 17 indexed citations
5.
Yang, Shih‐ying, Shin‐Hun Juang, Shang-Yuan Tsai, Pei-Dawn Lee Chao, & Yu‐Chi Hou. (2012). St. John's wort significantly increased the systemic exposure and toxicity of methotrexate in rats. Toxicology and Applied Pharmacology. 263(1). 39–43. 16 indexed citations
6.
Chen, I‐Li, Jih‐Jung Chen, Yu‐Chin Lin, et al.. (2012). Synthesis and antiproliferative activities of N-(naphthalen-2-yl)acetamide and N-(substituted phenyl)acetamide bearing quinolin-2(1H)-one and 3,4-dihydroquinolin-2(1H)-one derivatives. European Journal of Medicinal Chemistry. 59. 227–234. 12 indexed citations
7.
Wang, Liya, Tian-Shung Wu, Kimiyoshi Kaneko, et al.. (2011). Synthesis and antiproliferative evaluation of 3,5-disubstituted 1,2,4-triazoles containing flurophenyl and trifluoromethanephenyl moieties. Bioorganic & Medicinal Chemistry Letters. 21(18). 5358–5362. 22 indexed citations
8.
Chang, Ting‐Yu, Te‐Ling Lu, Hong‐Zin Lee, et al.. (2011). Genetic polymorphisms in oestrogen receptor‐binding sites affect clinical outcomes in patients with prostate cancer receiving androgen‐deprivation therapy. Journal of Internal Medicine. 271(5). 499–509. 39 indexed citations
9.
Huang, Chun‐Nung, Shu‐Pin Huang, Tzyh‐Chyuan Hour, et al.. (2011). Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer. World Journal of Urology. 31(2). 281–287. 11 indexed citations
10.
Huang, Ching‐Wen, Shu‐Pin Huang, Ta-Yuan Chang, et al.. (2011). Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy. Annals of Oncology. 23(3). 707–713. 47 indexed citations
11.
Bao, Bo‐Ying, Chun‐Nung Huang, Yeong‐Shiau Pu, et al.. (2010). Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy. Clinical Cancer Research. 17(4). 928–936. 64 indexed citations
12.
Huang, Yuying, Jiann‐Jyh Huang, Kimiyoshi Kaneko, et al.. (2010). Synthesis and antiproliferative evaluation of N,N-disubstituted-N′-[1-aryl-1H-pyrazol-5-yl]-methnimidamides. Bioorganic & Medicinal Chemistry Letters. 20(22). 6781–6784. 18 indexed citations
13.
Shia, Chi‐Sheng, Shin‐Hun Juang, Shang-Yuan Tsai, et al.. (2009). Metabolism and Pharmacokinetics of Anthraquinones inRheum palmatumin Rats andex vivoAntioxidant Activity. Planta Medica. 75(13). 1386–1392. 60 indexed citations
14.
Lin, Yi, et al.. (2005). Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(12). 3058–3062. 154 indexed citations
15.
Lee, Tzong‐Huei, Shin‐Hun Juang, Feng‐Lin Hsu, & Ching‐Yi Wu. (2005). Triterpene Acids from the Leaves ofPlanchonella Duclitan(Blanco) Bakhuizan. Journal of the Chinese Chemical Society. 52(6). 1275–1280. 60 indexed citations
16.
Chen, Li‐Tzong, Yee Chao, Jen‐Yea Chang, et al.. (2005). α‐fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. 22(3). 217–226. 41 indexed citations
17.
Juang, Shin‐Hun, Sung‐Jen Wei, Yi‐Mei Hung, et al.. (2004). IFN-β Induces Caspase-Mediated Apoptosis by Disrupting Mitochondria in Human Advanced Stage Colon Cancer Cell Lines. Journal of Interferon & Cytokine Research. 24(4). 231–243. 32 indexed citations
18.
Liu, Ko‐Jiunn, et al.. (2004). Expression of cytoplasmic-domain substituted epidermal growth factor receptor inhibits tumorigenicity of EGFR-overexpressed human glioblastoma multiforme. International Journal of Oncology. 24(3). 581–90. 11 indexed citations
19.
Juang, Shin‐Hun, et al.. (1996). Suppression of tumorigenicity and metastasis by murine melanoma cells infected with the pLXSN retrovirus carrying the inducible nitric oxide synthase gene. 37. 341. 1 indexed citations
20.
Juang, Shin‐Hun, et al.. (1996). Tyrosine phosphorylation at the membrane-microfilament interface: a p185neu-associated signal transduction particle containing Src, Abl and phosphorylated p58, a membrane- and microfilament-associated retroviral gag-like protein.. PubMed. 12(5). 1033–42. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026